Pura Vida Investments, LLC Cyma Bay Therapeutics, Inc. Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $499,140 - $1.5 Million	-354,000 Closed	0 $0
Q1 2020 Feb 12, 2021	BUY	$1.25 - $2.02 $438,075 - $707,929	350,460 Added 9900.0%	354,000 $524,000
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $404,325 - $653,389	-323,460 Reduced 98.92%	3,540 $35,000
Q4 2019 Feb 12, 2021	BUY	$1.33 - $5.93 $430,560 - $1.92 Million	323,730 Added 9900.0%	327,000 $641,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $394,650 - $1.76 Million	-296,730 Reduced 98.91%	3,270 $17,000
Q3 2019 Feb 12, 2021	BUY	$5.12 - $7.21 $1.52 Million - $2.14 Million	297,000 Added 9900.0%	300,000 $1.54 Million
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $15,360 - $21,630	3,000 New	3,000 $165,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.